You are here: Home » International » News » Politics
Business Standard

US cuts remaining dues payment to WHO after Donald Trump pulls out

The decision to withhold roughly $62 million in outstanding 2020 dues to the WHO is part of President Donald Trumps decision to withdraw from the organization over its handling of the coronavirus

Topics
World Health Organisation | WHO | Coronavirus

AP  |  Washington 

The United States played a pivotal role in helping to create the WHO in 1948. Just over 70 years later, President Trump is withdrawing the country from the agency amid the COVID-19 pandemic. Martial Trezzini/EPA
The United States played a pivotal role in helping to create the WHO in 1948. Just over 70 years later, President Trump is withdrawing the country from the agency amid the COVID-19 pandemic. Martial Trezzini/EPA

The Trump administration has said it won't pay more than USD 60 million in dues it owes to the and will use the money instead to pay down other contributions to the United Nations.

The announcement on Wednesday came just a day after the White House announced the US would not participate in a WHO-run project to develop and distribute a COVID-19 vaccine.

The decision to withhold roughly USD 62 million in outstanding 2020 dues to the is part of President Donald Trump's decision to withdraw from the organisation over its handling of the pandemic and his allegations that the agency has been improperly influenced by China.

Despite proceeding with the withdrawal, administration officials said the US will continue to participate in select meetings and make one-time contributions to specific programmes during a one-year wind-down period.

Those programmes include polio eradication projects in Afghanistan and Pakistan, humanitarian relief in Libya and Syria and efforts to combat influenza.

The funding decisions follow Trump's announcement in July that he was withdrawing the US from the effective July 2021 and instructing his administration to wind down funding and cooperation with the agency.

At the time of the announcement, the US had already paid about USD 52 million of its assessed 2020 dues of USD 120 million.

During the one-year wind-down, the officials said the US would continue to participate in select WHO technical and policy meetings that have a direct bearing on US health, commercial and national security interests.

We will consider those on a case-by-case basis, said Deputy Assistant Secretary of State for Organizations Nerissa Cook.

The officials, from the US Agency for Development and departments of State and Health and Human Services, did not say which other UN agencies would get the USD 62 million being withheld from WHO or whether it would be used to pay down US arrears to the world body's general fund.

Nor was it clear whether how the US would handle tens of millions of dollars in back dues it owes to the WHO. Under US law, arrears must be paid before the United States can withdraw from most organisations.

The one-time exemptions for specific programmes will apply to up to USD 40 million in funding for flu vaccination programs, according to Garrett Grigsby, the director of the HHS global affairs office, and up to USD 68 million for polio and Libya and Syria operations, according to USAID's Assistant Administrator for Global Health Dr Alma Golden.

On Tuesday, the administration announced it would not work with the vaccine project because it doesn't want to be constrained by multilateral groups like the WHO.

Some nations have worked directly to secure supplies of vaccine, but others are pooling efforts to ensure success against a disease that has no geographical boundaries. More than 150 countries are setting up the COVID-19 Vaccines Global Access Facility, or COVAX.

That cooperative effort, linked with the WHO, would allow nations to take advantage of a portfolio of potential vaccines to ensure their citizens are quickly covered by whichever ones are deemed effective.

The WHO says even governments making deals with individual vaccine makers would benefit from joining COVAX because it would provide backup vaccines in case the ones being made through bilateral deals with manufacturers aren't successful.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, September 03 2020. 11:34 IST
RECOMMENDED FOR YOU
.